I see others responded Spiderman and both have valid points. Goes back to risk/reward opportunity in my opinion. No doubt can move after R/S but as others have pointed out before, most OTC companies only care of getting there's with no products to show for it and sinks, but other times can run again as you already saw. We already have POWfolio, will it be enough by itself, can't predict that, but it is a product generating revenues (unfortunately without financials some don't care and that is fine, we all have to evaluate things best for ourselves).
ZWAGbox and Markiplier have to hit the shelves and mailboxes and this will absolutely move - even without financials in my opinion, as it did a couple months ago. And that only happened with POWfolio release.
I honestly don't feel R/S is happening, could be some debt sellers or retail just liquidating for some capital.
But, as another pointed out - buying is also happening. Glad you picked up some and wish I had some extra or I'd definitely grab more here. Just my opinion of course. docg
